While Kabaya states that creating pixel art is not as demanding as it might be perceived, in comparison to, say, the manual ...
TuHURA Biosciences, Inc. ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that it has ...